Gyre Therapeutics (GYRE) EBITDA Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -5,185.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,185.00 |
| Dec 31, 2025 | -2,480.00 |
| Sep 30, 2025 | 605.00 |
| Jun 30, 2025 | -455.00 |
| Mar 31, 2025 | -1,940.00 |
| Dec 31, 2024 | 33,991.00 |
| Sep 30, 2024 | -2,323.00 |
| Jun 30, 2024 | -430.00 |
| Mar 31, 2024 | 297.00 |
| Dec 31, 2023 | -31,540.00 |
| Mar 31, 2023 | 187,824.00 |
| Dec 31, 2022 | 81,037.00 |
| Mar 31, 2022 | -32,200.00 |
| Dec 31, 2021 | 9,517.00 |
| Sep 30, 2021 | 70,552.00 |
| Jun 30, 2021 | -71,208.00 |
| Mar 31, 2021 | -149,855.00 |
| Mar 31, 2018 | -10.98 Mn |
| Dec 31, 2017 | 551,909.00 |
| Sep 30, 2017 | 339,194.00 |
| Jun 30, 2017 | -84,578.00 |
| Mar 31, 2017 | 265,538.00 |
| Dec 31, 2016 | -305,578.00 |
| Sep 30, 2016 | -167,615.00 |
| Jun 30, 2016 | -400,300.00 |
| Mar 31, 2016 | -319,256.00 |
| Dec 31, 2015 | -360,005.00 |
| Sep 30, 2015 | -266,568.00 |
| Jun 30, 2015 | 221,841.00 |
| Mar 31, 2015 | 405,530.00 |
| Dec 31, 2014 | 1.37 Mn |
| Mar 31, 2014 | -482,876.00 |
| Dec 31, 2013 | -1.17 Mn |
| Mar 31, 2013 | -23,920.00 |
| Dec 31, 2012 | -266,611.00 |
| Sep 30, 2012 | -95,286.00 |
| Jun 30, 2012 | 5,537.00 |
| Mar 31, 2012 | -2,208.00 |
| Dec 31, 2011 | -4,736.00 |
| Sep 30, 2011 | -182,643.00 |
| Jun 30, 2011 | -252,048.00 |